Intragenic deletions of GNAS in pseudohypoparathyroidism type 1A identify a new region affecting methylation of exon A/B.

CONTEXT Pseudohypoparathyroidism type 1A (PHP1A) and pseudopseudohypoparathyroidism (PPHP) are caused by inactivating mutations in the exons of GNAS that encode the alpha-subunit of the stimulatory G protein (Gsα). In some cases abnormal methylation of exon A/B of GNAS, a hallmark of PHP1B, has been reported. OBJECTIVE To identify the underlying genetic basis for PHP1A/PPHP in patients in whom molecular defects were not detected by GNAS sequencing and microarray-based analysis of copy number variations. METHODS Whole genome sequencing and pyrosequencing of differentially methylated regions (DMRs) of GNAS using genomic DNA from affected patients. RESULTS We identified two novel heterozygous GNAS deletions: a 6.4-Kb deletion that includes exon 2 of GNAS in the first proband that was associated with normal methylation (57%) of exon A/B DMR, and a 1,438-bp deletion in a second PHP1A patient that encompasses the promoter region and 5'UTR of Gsα transcripts, which was inherited from his mother with PPHP. This deletion was associated with reduced methylation (32%) of exon A/B DMR. CONCLUSIONS WGS can detect exonic and intronic mutations, including deletions that are too small to be identified by microarray analysis, and therefore is more sensitive than other techniques for molecular analysis of PHP1A/PPHP. One of the deletions we identified led to reduced methylation of exon A/B DMR, further refining a region needed for normal imprinting of this DMR. We propose that deletion of this region can explain why some PHP1A patients have reduced of methylation of the exon A/B DMR.

[1]  O. Mäkitie,et al.  Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement , 2018, Nature Reviews Endocrinology.

[2]  H. Jüppner,et al.  A novel deletion involving GNAS exon 1 causes PHP1A and further refines the region required for normal methylation at exon A/B. , 2017, Bone.

[3]  G. Mantovani,et al.  Pseudohypoparathyroidism and Gsα–cAMP-linked disorders: current view and open issues , 2016, Nature Reviews Endocrinology.

[4]  Xiaoyu Chen,et al.  Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..

[5]  J. Lupski,et al.  Mechanisms underlying structural variant formation in genomic disorders , 2016, Nature Reviews Genetics.

[6]  Mark Yandell,et al.  Wham: Identifying Structural Variants of Biological Consequence , 2015, PLoS Comput. Biol..

[7]  O. Mäkitie,et al.  TSH Elevations as the First Laboratory Evidence for Pseudohypoparathyroidism Type Ib (PHP‐Ib) , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  J. Clarke,et al.  Novel microdeletions affecting the GNAS locus in pseudohypoparathyroidism: characterization of the underlying mechanisms. , 2015, The Journal of clinical endocrinology and metabolism.

[9]  Ryan M. Layer,et al.  SpeedSeq: Ultra-fast personal genome analysis and interpretation , 2014, Nature Methods.

[10]  J. Grötzinger,et al.  A positive genotype–phenotype correlation in a large cohort of patients with Pseudohypoparathyroidism Type Ia and Pseudo-pseudohypoparathyroidism and 33 newly identified mutations in the GNAS gene , 2014, Molecular genetics & genomic medicine.

[11]  R. Thakker,et al.  GNAS Mutations in Pseudohypoparathyroidism Type 1a and Related Disorders , 2014, Human mutation.

[12]  T. Prescott,et al.  Very small deletions within the NESP55 gene in pseudohypoparathyroidism type 1b , 2014, European Journal of Human Genetics.

[13]  V. Bollati,et al.  Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations. , 2014, The Journal of clinical endocrinology and metabolism.

[14]  Todd Richmond,et al.  Detection of Clinically Relevant Copy Number Variants with Whole‐Exome Sequencing , 2013, Human mutation.

[15]  M. Bastepe Genetics and epigenetics of parathyroid hormone resistance. , 2013, Endocrine development.

[16]  M. Levine An update on the clinical and molecular characteristics of pseudohypoparathyroidism , 2012, Current opinion in endocrinology, diabetes, and obesity.

[17]  Ryan M. Layer,et al.  LUMPY: a probabilistic framework for structural variant discovery , 2012, Genome Biology.

[18]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[19]  J. Andrieux,et al.  A new deletion ablating NESP55 causes loss of maternal imprint of A/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib. , 2012, The Journal of clinical endocrinology and metabolism.

[20]  T. Hasegawa,et al.  A family of pseudohypoparathyroidism type Ia with an 850‐kb submicroscopic deletion encompassing the whole GNAS locus , 2012, American journal of medical genetics. Part A.

[21]  U. Frey,et al.  A novel aspect of GNAS imprinting: Higher maternal expression of Gαs in human lymphoblasts, peripheral blood mononuclear cells, mammary adipose tissue, and heart , 2011, Molecular and Cellular Endocrinology.

[22]  M. Gerstein,et al.  CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. , 2011, Genome research.

[23]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[24]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[25]  H. Jüppner,et al.  Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis. , 2010, The Journal of clinical endocrinology and metabolism.

[26]  V. Bollati,et al.  Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. , 2010, The Journal of clinical endocrinology and metabolism.

[27]  C. Largo,et al.  Intragenic GNAS deletion involving exon A/B in pseudohypoparathyroidism type 1A resulting in an apparent loss of exon A/B methylation: potential for misdiagnosis of pseudohypoparathyroidism type 1B. , 2010, The Journal of clinical endocrinology and metabolism.

[28]  R. Wilson,et al.  BreakDancer: An algorithm for high resolution mapping of genomic structural variation , 2009, Nature Methods.

[29]  J. Lupski,et al.  Mechanisms of change in gene copy number , 2009, Nature Reviews Genetics.

[30]  O. Gavrilova,et al.  Central nervous system imprinting of the G protein G(s)alpha and its role in metabolic regulation. , 2009, Cell metabolism.

[31]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[32]  E. Fernandez-Rebollo,et al.  New mutation type in pseudohypoparathyroidism type Ia , 2008, Clinical endocrinology.

[33]  U. Yasar,et al.  Molecular Diagnosis and Clinical Characterization of Pseudohypoparathyroidism Type-Ib in a Patient With Mild Albright's Hereditary Osteodystrophy-Like Features, Epileptic Seizures, and Defective Renal Handling of Uric Acid , 2008, The American journal of the medical sciences.

[34]  Stéphanie Maupetit-Méhouas,et al.  A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance. , 2008, The Journal of clinical endocrinology and metabolism.

[35]  J. Lupski,et al.  A DNA Replication Mechanism for Generating Nonrecurrent Rearrangements Associated with Genomic Disorders , 2007, Cell.

[36]  I. Santin,et al.  Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy. , 2007, The Journal of clinical endocrinology and metabolism.

[37]  A. Munnich,et al.  Paternal deletion of the GNAS imprinted locus (including Gnasxl) in two girls presenting with severe pre- and post-natal growth retardation and intractable feeding difficulties , 2005, European Journal of Human Genetics.

[38]  P. Beck‐Peccoz,et al.  Biallelic Expression of the Gsα Gene in Human Bone and Adipose Tissue , 2004 .

[39]  A. Tsatsoulis,et al.  Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. , 2003, The Journal of clinical investigation.

[40]  L. Weinstein,et al.  The Stimulatory G Protein α-Subunit Gsα Is Imprinted in Human Thyroid Glands: Implications for Thyroid Function in Pseudohypoparathyroidism Types 1A and 1B , 2003 .

[41]  R. Trembath,et al.  Constitutional deletion of chromosome 20q in two patients affected with albright hereditary osteodystrophy. , 2002, American journal of medical genetics.

[42]  P. Beck‐Peccoz,et al.  The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. , 2002, The Journal of clinical endocrinology and metabolism.

[43]  P. Stankiewicz,et al.  Genome architecture, rearrangements and genomic disorders. , 2002, Trends in genetics : TIG.

[44]  M. Zasloff,et al.  Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. , 2002, The New England journal of medicine.

[45]  G. Hendy,et al.  Galphas transcripts are biallelically expressed in the human kidney cortex: implications for pseudohypoparathyroidism type 1b. , 2001, The Journal of clinical endocrinology and metabolism.

[46]  H. Jüppner,et al.  Paternal uniparental isodisomy of chromosome 20q--and the resulting changes in GNAS1 methylation--as a plausible cause of pseudohypoparathyroidism. , 2001, American journal of human genetics.

[47]  W. Mcalister,et al.  Deficiency of the α‐Subunit of the Stimulatory G Protein and Severe Extraskeletal Ossification , 2000 .

[48]  L. Biesecker,et al.  A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. , 2000, The Journal of clinical investigation.

[49]  L. Weinstein,et al.  Variable imprinting of the heterotrimeric G protein Gsα-subunit within different segments of the nephron , 2000 .

[50]  D. Bonthron,et al.  An imprinted antisense transcript at the human GNAS1 locus. , 2000, Human molecular genetics.

[51]  D. Bonthron,et al.  Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Lupski Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. , 1998, Trends in genetics : TIG.

[53]  D. Bonthron,et al.  The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Brickman,et al.  Pseudohypoparathyroidism type Ia from maternal but not paternal transmission of a Gsalpha gene mutation. , 1998, American journal of medical genetics.

[55]  W. Born,et al.  An inherited mutation associated with functional deficiency of the alpha-subunit of the guanine nucleotide-binding protein Gs in pseudo- and pseudopseudohypoparathyroidism. , 1998, The Journal of clinical endocrinology and metabolism.

[56]  S. Davies,et al.  Imprinting in Albright's hereditary osteodystrophy. , 1993, Journal of medical genetics.

[57]  S. O’Brien,et al.  Mapping of the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase (GNAS1) to 20q13.2----q13.3 in human by in situ hybridization. , 1991, Genomics.

[58]  E. Gershon,et al.  Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[59]  D. Valle,et al.  Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. , 1990, The New England journal of medicine.

[60]  김재호,et al.  Pseudo-Pseudohypoparathyroidism - 증례 보고 , 1978 .

[61]  W. Reed,et al.  Albright's hereditary osteodystrophy with cutaneous bone formation. , 1971, Archives of dermatology.

[62]  H. Jüppner,et al.  Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib , 2005, Nature Genetics.

[63]  H. Jüppner,et al.  GNAS locus and pseudohypoparathyroidism. , 2005, Hormone research.